TACROLIMUS Side Effects

7028175-9 | Jaw Disorder, Swelling
on Sep 20, 2010 Male patient from UNITED STATES , child 8 years of age, was diagnosed with dermatitis atopic and was treated with Tacrolimus (View Usage). Patient experienced the following unwanted or unexpected effects: jaw disorder, swelling. Tacrolimus dosage: 0.1 %, /d, Topical.

7027464-1 | Lymphadenopathy
Patient was taking Tacrolimus (View Usage). Patient had the following side effects: lymphadenopathy on Sep 21, 2010 from UNITED KINGDOM Additional patient health information: Female patient , child 7 years of age, was diagnosed with dermatitis atopic and. Tacrolimus dosage: 0.03 %, Prn, Topical. During the same period patient was treated with DERMOL (PREDNISOLONE) (View Dermol (prednisolone) Review and Dermol (prednisolone) Label ), EMOLENE (DIAZOLIDINYL UREA, DIMETICONE, PROPYLENE GLYCOL) (View Emolene (diazolidinyl Urea, Dimeticone, Propylene Glycol) Review and Emolene (diazolidinyl Urea, Dimeticone, Propylene Glycol) Label ), SYNALAR (NEOMYCIN) (View Synalar (neomycin) Review and Synalar (neomycin) Label ), METOSYN (FLUOCINONIDE) (View Metosyn (fluocinonide) Review and Metosyn (fluocinonide) Label ).

7027457-4 | Blood Creatinine Increased, Blood Potassium Increased, Blood Urea Increased
Adverse event was reported on Sep 21, 2010 by a Male patient taking Tacrolimus (View Usage) (Dosage: 3 Mg, /d, Oral ; 1 Mg, /d, Oral) was diagnosed with myasthenia gravis and. Location: JAPAN , 56 years of age, weighting 184.1 lb, After Tacrolimus was administered, patient had the following side effects: blood creatinine increased, blood potassium increased, blood urea increased. During the same period patient was treated with EPLERENONE (Oral) (View Eplerenone Review and Eplerenone Label ), TICLOPIDINE HCL (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), MUCOSTA (REBAMIPIDE) (View Mucosta (rebamipide) Review and Mucosta (rebamipide) Label ).

7027453-7 | Hypogammaglobulinaemia, Osteoporosis
on Sep 21, 2010 Male patient from JAPAN , 50 years of age, weighting 134.5 lb, was diagnosed with heart transplant (What is heart transplant?) and was treated with Tacrolimus (View Usage). Patient experienced the following unwanted or unexpected effects: hypogammaglobulinaemia, osteoporosis (What is osteoporosis?). Tacrolimus dosage: See Image.


7021877-X | Cerebral Haemorrhage
on Sep 16, 2010 Female patient from SPAIN , 59 years of age, was diagnosed with heart transplant (What is heart transplant?) and was treated with Tacrolimus (View Usage). Patient had the following side effects: cerebral haemorrhage. Tacrolimus dosage: . During the same period patient was treated with ANTI THYMOCYTE GLOBULIN NOS (View Anti-thymocyte Globulin Nos Review and Anti-thymocyte Globulin Nos Label ).

7019543-X | Bronchiolitis, Bronchitis, Food Allergy, Hypovolaemia, No Therapeutic Response, Otitis Media, Respiratory Distress, Tachypnoea, Tonsillitis
Patient was taking Tacrolimus (View Usage). After Tacrolimus was administered, patient had the following side effects: bronchiolitis, bronchitis (What is bronchitis?), food allergy (What is food allergy?), hypovolaemia, no therapeutic response, otitis media, respiratory distress, tachypnoea, tonsillitis on Sep 14, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 97.00 lb, was diagnosed with dermatitis atopic and. Tacrolimus dosage: 0.1 %, Bid, Topical. During the same period patient was treated with PIMECROLIMUS (PIMECROLIMUS, PIMECROLIMUS) (View Pimecrolimus (pimecrolimus, Pimecrolimus) Review and Pimecrolimus (pimecrolimus, Pimecrolimus) Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), XYZAL (LEVOCETRIZIINE DIHYDROCHLORIDE) (View Xyzal (levocetriziine Dihydrochloride) Review and Xyzal (levocetriziine Dihydrochloride) Label ). Patient was hospitalized.

7018288-X | Blood Uric Acid Increased, Dna Antibody Positive, Gastroenteritis Salmonella, Grand Mal Convulsion, Haematocrit Decreased, Haemorrhage, Hyponatraemia
Adverse event was reported on Sep 16, 2010 by a Female patient taking Tacrolimus (View Usage) (Dosage: 3 Mg, /d, Oral ; 3 Mg, /d, Oral ; 2.5 Mg, /d, Oral) was diagnosed with lupus nephritis and. Location: JAPAN , 32 years of age, weighting 103.6 lb, Patient experienced the following unwanted or unexpected effects: blood uric acid increased, dna antibody positive, gastroenteritis salmonella, grand mal convulsion, haematocrit decreased, haemorrhage, hyponatraemia. During the same period patient was treated with PREDNISOLONE (See Image) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

7018238-6 | Caesarean Section, Hypertension, Pregnancy, Premature Labour
on Sep 10, 2010 Female patient from IRELAND , weighting 163.1 lb, was diagnosed with renal transplant and was treated with Tacrolimus (View Usage). Patient had the following side effects: caesarean section, hypertension, pregnancy (What is pregnancy?), premature labour. Tacrolimus dosage: 5 Mg, /d, Oral. During the same period patient was treated with PRENDISOLONE (PREDNISOLONE) (View Prendisolone (prednisolone) Review and Prendisolone (prednisolone) Label ), IMURAN (View Imuran Review and Imuran Label ), CALCICHEW D3 FORTE (CALCIUM CARBONATE, COLECALCIFEROL) (View Calcichew D3 Forte (calcium Carbonate, Colecalciferol) Review and Calcichew D3 Forte (calcium Carbonate, Colecalciferol) Label ), NITROFURANTOIN (View Nitrofurantoin Review and Nitrofurantoin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

7018221-0 | Caesarean Section, Foetal Cardiac Disorder, Foetal Growth Restriction, Jaundice Neonatal, Neonatal Respiratory Distress Syndrome, Premature Baby
on Sep 10, 2010 Male patient from IRELAND , weighting 4.19 lb, was treated with Tacrolimus (View Usage). After Tacrolimus was administered, patient had the following side effects: caesarean section, foetal cardiac disorder, foetal growth restriction, jaundice neonatal, neonatal respiratory distress syndrome, premature baby. Tacrolimus dosage: 5 Mg, /d, Transplacental. During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), CALCICHEW D3 FORTE (CALCIUM CARBONATE, COLECALCIFEROL) (View Calcichew D3 Forte (calcium Carbonate, Colecalciferol) Review and Calcichew D3 Forte (calcium Carbonate, Colecalciferol) Label ), NITROFURANTOIN (View Nitrofurantoin Review and Nitrofurantoin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

7015361-7 | Head Injury, Skeletal Injury
Patient was taking Tacrolimus (View Usage). Patient experienced the following unwanted or unexpected effects: head injury, skeletal injury on Sep 09, 2010 from GERMANY Additional patient health information: Female patient , child 7 years of age, weighting 44.09 lb, was diagnosed with dermatitis atopic and. Tacrolimus dosage: Topical. Patient was hospitalized.

7009348-8 | Abnormal Behaviour, Anxiety, Apraxia, Brain Injury, Cerebral Arteritis, Cerebral Ischaemia, Coma, Coordination Abnormal, Disorientation
Adverse event was reported on Sep 10, 2010 by a Male patient taking Tacrolimus (View Usage) (Dosage: ) was diagnosed with liver transplant (What is liver transplant?) and. Location: ITALY , 53 years of age, Patient had the following side effects: abnormal behaviour, anxiety (What is anxiety?), apraxia, brain injury, cerebral arteritis, cerebral ischaemia, coma, coordination abnormal, disorientation. During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ). Patient was hospitalized.

7007713-6 | Transient Ischaemic Attack
on Sep 07, 2010 Female patient from TAIWAN, PROVINCE OF CHINA , 58 years of age, was diagnosed with liver transplant (What is liver transplant?) and was treated with Tacrolimus (View Usage). After Tacrolimus was administered, patient had the following side effects: transient ischaemic attack. Tacrolimus dosage: See Image. Patient was hospitalized.

7006575-0 | Microangiopathic Haemolytic Anaemia, Thrombotic Thrombocytopenic Purpura
on Sep 21, 2010 Female patient from UNITED STATES , weighting 150.0 lb, was treated with Tacrolimus (View Usage). Patient experienced the following unwanted or unexpected effects: microangiopathic haemolytic anaemia, thrombotic thrombocytopenic purpura. Tacrolimus dosage: 0.5 Mg Po. Patient was hospitalized.

7005528-6 | Infectious Mononucleosis, Lymphadenopathy
Patient was taking Tacrolimus (View Usage). Patient had the following side effects: infectious mononucleosis (What is infectious mononucleosis?), lymphadenopathy on Jul 26, 2010 from POLAND Additional patient health information: Female patient , child 8 years of age, weighting 48.50 lb, was diagnosed with dermatitis atopic and. Tacrolimus dosage: 0.1 %,. During the same period patient was treated with DIPROGENT (BETAMETHASONE) (View Diprogent (betamethasone) Review and Diprogent (betamethasone) Label ), ATARAX (ALPRAZOLAM) (View Atarax (alprazolam) Review and Atarax (alprazolam) Label ). Patient was hospitalized.

7003539-8 | Autoimmune Pancreatitis, Diarrhoea, Folliculitis, Incisional Hernia, Transplant Failure
Adverse event was reported on Sep 07, 2010 by a Male patient taking Tacrolimus (View Usage) (Dosage: See Image) was diagnosed with pancreas transplant (What is pancreas transplant?) and. Location: JAPAN , 44 years of age, After Tacrolimus was administered, patient had the following side effects: autoimmune pancreatitis, diarrhoea, folliculitis, incisional hernia, transplant failure. Patient was hospitalized and became disabled.

7003218-7 | Abortion Spontaneous, Pregnancy
on Sep 07, 2010 Female patient from UNITED STATES , 19 years of age, was diagnosed with dermatitis atopic and was treated with Tacrolimus (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous, pregnancy (What is pregnancy?). Tacrolimus dosage: 0.1%, /d, Topical. Patient was hospitalized.

6987826-5 | Chorioretinitis, Fungal Infection, Fungal Skin Infection, Retinal Exudates, Retinal Haemorrhage, Scotoma, Visual Acuity Reduced
on Sep 07, 2010 Male patient from AUSTRALIA , 43 years of age, was diagnosed with stem cell transplant and was treated with Tacrolimus (View Usage). Patient had the following side effects: chorioretinitis, fungal infection (What is fungal infection?), fungal skin infection, retinal exudates, retinal haemorrhage, scotoma, visual acuity reduced. Tacrolimus dosage: . During the same period patient was treated with VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), POSACONAZOLE (View Posaconazole Review and Posaconazole Label ), TERBINAFINE HCL (View Terbinafine Hcl Review and Terbinafine Hcl Label ), CASPOFUNGIN (CASPOFUNGIN) (View Caspofungin (caspofungin) Review and Caspofungin (caspofungin) Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ).

6983207-9 | Hypersensitivity
Patient was taking Tacrolimus (View Usage). After Tacrolimus was administered, patient had the following side effects: hypersensitivity on Aug 25, 2010 from UNITED STATES Additional patient health information: Male patient , child 9 years of age, was diagnosed with dermatitis atopic and. Tacrolimus dosage: 0.1%, Topical.

6979894-1 | Bronchitis, Conjunctivitis Allergic, Gastroenteritis, Gingivitis, Infection, Influenza, Insomnia, Iron Deficiency Anaemia, Mania
Adverse event was reported on Aug 30, 2010 by a Female patient taking Tacrolimus (View Usage) (Dosage: 3 Mg, Oral) was diagnosed with lupus nephritis and. Location: JAPAN , 26 years of age, Patient experienced the following unwanted or unexpected effects: bronchitis (What is bronchitis?), conjunctivitis allergic, gastroenteritis (What is gastroenteritis?), gingivitis, infection (What is infection?), influenza, insomnia, iron deficiency anaemia, mania. During the same period patient was treated with PREDNISOLONE (10 Mg, Oral; 9 Mg, Oral; 8 Mg, Oral; 45 Mg, Oral) (View Prednisolone Review and Prednisolone Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), MICARDIS (View Micardis Review and Micardis Label ), GASTER (FAMOTIDINE) ORODISPERSIBLE CR TABLET (View Gaster (famotidine) Orodispersible Cr Tablet Review and Gaster (famotidine) Orodispersible Cr Tablet Label ), BUFFERIN (ACETYLSALICYLIC ACID, ALUMINIUM GLYCINATE) PER ORAL NOS (View Bufferin (acetylsalicylic Acid, Aluminium Glycinate) Per Oral Nos Review and Bufferin (acetylsalicylic Acid, Aluminium Glycinate) Per Oral Nos Label ).

6979892-8 | Sjogren's Syndrome
on Aug 30, 2010 Male patient from JAPAN , 71 years of age, weighting 138.9 lb, was diagnosed with lupus nephritis and was treated with Tacrolimus (View Usage). Patient had the following side effects: sjogren's syndrome (What is sjogren's syndrome?). Tacrolimus dosage: 1 Mg, Oral; 3 Mg, Oral. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LOSARTAN POTASSIUM W/HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE, LOSARTA (View Losartan Potassium W/hydrochlorothiazide (hydrochlorothiazide, Losarta Review and Losartan Potassium W/hydrochlorothiazide (hydrochlorothiazide, Losarta Label ), ADALAT CR (NIFEDIPINE) PER ORAL NOS (View Adalat Cr (nifedipine) Per Oral Nos Review and Adalat Cr (nifedipine) Per Oral Nos Label ), BENET (RISEDRONATE SODIUM) PER ORAL NOS (View Benet (risedronate Sodium) Per Oral Nos Review and Benet (risedronate Sodium) Per Oral Nos Label ), PERSANTIN L (DIPYRIDAMOLE) PER ORAL NOS (View Persantin-l (dipyridamole) Per Oral Nos Review and Persantin-l (dipyridamole) Per Oral Nos Label ).

6979891-6 | Aspergillosis, Pulmonary Oedema, Renal Failure, Respiratory Failure
on Sep 02, 2010 Male patient from AUSTRALIA , 15 years of age, was diagnosed with liver transplant (What is liver transplant?) and was treated with Tacrolimus (View Usage). After Tacrolimus was administered, patient had the following side effects: aspergillosis, pulmonary oedema, renal failure, respiratory failure. Tacrolimus dosage: .

6979890-4 | Abdominal Pain, Abdominal Symptom, Burkitt's Lymphoma, Device Related Infection, Device Related Sepsis, Epstein-barr Virus Associated Lymphoproliferative Disorder, Epstein-barr Virus Infection, Haemodialysis, Lymphadenopathy
Patient was taking Tacrolimus (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), abdominal symptom, burkitt's lymphoma, device related infection, device related sepsis, epstein-barr virus associated lymphoproliferative disorder, epstein-barr virus infection, haemodialysis, lymphadenopathy on Aug 27, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 13 years of age, was diagnosed with heart transplant (What is heart transplant?) and. Tacrolimus dosage: . During the same period patient was treated with THIOGUANINE (View Thioguanine Review and Thioguanine Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), DEXRAZOXANE (View Dexrazoxane Review and Dexrazoxane Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), METHOTREXATE (Total Dose, Intrathecal) (View Methotrexate Review and Methotrexate Label ).

6973539-2 | Dysarthria, Muscular Weakness, Transient Ischaemic Attack
Adverse event was reported on Aug 26, 2010 by a Female patient taking Tacrolimus (View Usage) (Dosage: See Image) was diagnosed with liver transplant (What is liver transplant?) and. Location: TAIWAN, PROVINCE OF CHINA , 58 years of age, Patient had the following side effects: dysarthria, muscular weakness, transient ischaemic attack. Patient was hospitalized.

6970149-8 | Acute Respiratory Distress Syndrome, Acute Respiratory Failure, Ascites, Autoimmune Thrombocytopenia, Cardio-respiratory Arrest, Condition Aggravated, Cytomegalovirus Test Positive, Diarrhoea
on Aug 27, 2010 Female patient from JAPAN , 72 years of age, weighting 126.8 lb, was diagnosed with interstitial lung disease and was treated with Tacrolimus (View Usage). After Tacrolimus was administered, patient had the following side effects: acute respiratory distress syndrome, acute respiratory failure, ascites, autoimmune thrombocytopenia, cardio-respiratory arrest, condition aggravated, cytomegalovirus test positive, diarrhoea. Tacrolimus dosage: 0.5 Mg, Bid, Oral; 2 Mg, Bid, Oral; 1.5 Mg, Bid, Oral; 2.5 Mg, /d, Oral. During the same period patient was treated with PREDNISOLONE TAB (View Prednisolone Tab Review and Prednisolone Tab Label ), PREDOHAN (PREDNISOLONE) TABLET (View Predohan (prednisolone) Tablet Review and Predohan (prednisolone) Tablet Label ), LASIX (View Lasix Review and Lasix Label ), FUNGIZONE (View Fungizone Review and Fungizone Label ), LOPERANIL (LOPERAMIDE HYDROCHLORIDE) CAPSULE (View Loperanil (loperamide Hydrochloride) Capsule Review and Loperanil (loperamide Hydrochloride) Capsule Label ). Patient was hospitalized.

6970015-8 | Asthma, Condition Aggravated
on Aug 24, 2010 Male patient from UNITED STATES , child 10 years of age, was diagnosed with dermatitis atopic and was treated with Tacrolimus (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), condition aggravated. Tacrolimus dosage: . Patient was hospitalized.

6969398-4 | Abdominal Distension, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Blood Pressure Decreased, Blood Uric Acid Increased, Condition Aggravated, Constipation, Diabetes Mellitus
Patient was taking Tacrolimus (View Usage). Patient had the following side effects: abdominal distension, alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood pressure decreased, blood uric acid increased, condition aggravated, constipation (What is constipation?), diabetes mellitus on Aug 24, 2010 from JAPAN Additional patient health information: Female patient , 42 years of age, weighting 194.2 lb, was diagnosed with lupus nephritis and. Tacrolimus dosage: 3 Mg, /d, Oral. During the same period patient was treated with BUMETANIDE (1 Mg, /d, Oral) (View Bumetanide Review and Bumetanide Label ), LASIX (20 Mg, /d, Oral) (View Lasix Review and Lasix Label ), ALDACTONE (254 Mg, /d, Oral) (View Aldactone Review and Aldactone Label ), PREDNISOLONE (5 Mg, /d, Oral) (View Prednisolone Review and Prednisolone Label ), HALOPERIDOL (0.75 Mg, /d, Oral) (View Haloperidol Review and Haloperidol Label ), PAXIL (20 Mg, /d, Oral) (View Paxil Review and Paxil Label ), DIOVAN (80 Mg, /d, Oral; 40 Mg, /d, Oral) (View Diovan Review and Diovan Label ). Patient was hospitalized.

6969396-0 | Bronchopulmonary Aspergillosis, Kidney Transplant Rejection
Adverse event was reported on Aug 26, 2010 by a Male patient taking Tacrolimus (View Usage) (Dosage: ) was diagnosed with renal transplant and. Location: GERMANY , 56 years of age, After Tacrolimus was administered, patient had the following side effects: bronchopulmonary aspergillosis, kidney transplant rejection. During the same period patient was treated with MYCOPHENOLATE MOFETIL (2 G, Uid/qd) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CORTICOSTEROID NOS (CORTICOSTEROID NOS) (View Corticosteroid Nos (corticosteroid Nos) Review and Corticosteroid Nos (corticosteroid Nos) Label ), BASILIXIMAB (BASILIXIMAB) (View Basiliximab (basiliximab) Review and Basiliximab (basiliximab) Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6960993-5 | Coma, Nervous System Disorder, Renal Failure, Vasculitis Cerebral
on Aug 23, 2010 Male patient from ITALY , 53 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with Tacrolimus (View Usage). Patient experienced the following unwanted or unexpected effects: coma, nervous system disorder, renal failure, vasculitis cerebral. Tacrolimus dosage: Unk.

6960934-0 | Optic Ischaemic Neuropathy
on Aug 20, 2010 Male patient from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF , 54 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with Tacrolimus (View Usage). Patient had the following side effects: optic ischaemic neuropathy. Tacrolimus dosage: 2.5 Mg, Bid.

6959344-1 | Product Quality Issue
Patient was taking Tacrolimus (View Usage). After Tacrolimus was administered, patient had the following side effects: product quality issue on Aug 31, 2010 from UNITED STATES Additional patient health information: Male patient , 20 years of age, weighting 127.9 lb, was diagnosed with renal transplant, transplant rejection and. Tacrolimus dosage: 4 Bid Po.

6956811-1 | Chorioretinopathy, Renal Disorder
Adverse event was reported on Aug 17, 2010 by a Female patient taking Tacrolimus (View Usage) (Dosage: 1 Mg, Oral; 2 Mg, Oral) was diagnosed with lupus nephritis and. Location: JAPAN , 58 years of age, weighting 98.77 lb, Patient experienced the following unwanted or unexpected effects: chorioretinopathy, renal disorder. During the same period patient was treated with PREDNISOLONE (See Image) (View Prednisolone Review and Prednisolone Label ).

6942093-3 | Asthenia, Blood Creatinine Increased, Diarrhoea, Hirsutism, Humerus Fracture, Nephropathy Toxic
on Jul 30, 2010 Female patient from SPAIN , 55 years of age, was diagnosed with renal transplant and was treated with Tacrolimus (View Usage). Patient had the following side effects: asthenia, blood creatinine increased, diarrhoea, hirsutism, humerus fracture, nephropathy toxic. Tacrolimus dosage: . During the same period patient was treated with CORTICOSTEROIDS () (View Corticosteroids () Review and Corticosteroids () Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), ANTI THYMOCYTE GLOBULIN NOS (View Anti-thymocyte Globulin Nos Review and Anti-thymocyte Globulin Nos Label ). Patient was hospitalized.

6941448-0 | Hallucination, Visual Impairment
on Aug 24, 2010 Male patient from UNITED STATES , weighting 158.1 lb, was treated with Tacrolimus (View Usage). After Tacrolimus was administered, patient had the following side effects: hallucination, visual impairment. Tacrolimus dosage: 2.1mg Iv. Patient was hospitalized.

6936852-0 | Jaw Disorder, Swelling
Patient was taking Tacrolimus (View Usage). Patient experienced the following unwanted or unexpected effects: jaw disorder, swelling on Aug 09, 2010 from UNITED STATES Additional patient health information: Male patient , child 8 years of age, was diagnosed with dermatitis atopic and. Tacrolimus dosage: 0.1 %, Topical. Patient was hospitalized.

6936719-8 | Arthralgia, Cystitis, Diarrhoea, Fall, Nasopharyngitis, Osteonecrosis, Rhinitis, Upper Respiratory Tract Inflammation, Urinary Tract Infection
Adverse event was reported on Aug 09, 2010 by a Female patient taking Tacrolimus (View Usage) (Dosage: 3 Mg, /d, Oral; 3mg,/d, Oral; 1 Mg, /d, Oral; 2mg, /d, Oral; 2.5mg, /d, Oral) was diagnosed with lupus nephritis and. Location: JAPAN , 26 years of age, weighting 121.3 lb, Patient had the following side effects: arthralgia, cystitis, diarrhoea, fall (What is fall?), nasopharyngitis, osteonecrosis (What is osteonecrosis?), rhinitis, upper respiratory tract inflammation, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with PREDNISOLONE (See Image) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized and became disabled.

6929967-4 | Asthenia, Diarrhoea, Humerus Fracture, Nephropathy Toxic, Oliguria, Renal Papillary Necrosis
on Jul 30, 2010 Female patient from SPAIN , 55 years of age, was diagnosed with renal transplant and was treated with Tacrolimus (View Usage). After Tacrolimus was administered, patient had the following side effects: asthenia, diarrhoea, humerus fracture, nephropathy toxic, oliguria, renal papillary necrosis. Tacrolimus dosage: . During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), ANTI THYMOCYTE GLOBULIN NOS (View Anti-thymocyte Globulin Nos Review and Anti-thymocyte Globulin Nos Label ). Patient was hospitalized.

6929271-4 | Abdominal Distension, Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Blood Pressure Decreased, Blood Uric Acid Increased, Condition Aggravated, Constipation
on Aug 03, 2010 Female patient from JAPAN , 42 years of age, weighting 194.2 lb, was diagnosed with lupus nephritis and was treated with Tacrolimus (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood pressure decreased, blood uric acid increased, condition aggravated, constipation (What is constipation?). Tacrolimus dosage: 3 Mg, D, Oral. During the same period patient was treated with BUMETANIDE (1 Mg, D, Oral) (View Bumetanide Review and Bumetanide Label ), LASIX (20 Mg, D, Oral) (View Lasix Review and Lasix Label ), ALDACTONE (25 Mg, D, Oral) (View Aldactone Review and Aldactone Label ), PREDNISOLONE (5 Mg, D, Oral) (View Prednisolone Review and Prednisolone Label ), HALOPERIDOL (0.75 Mg, D, Oral) (View Haloperidol Review and Haloperidol Label ), PAXIL (20 Mg,d, Oral) (View Paxil Review and Paxil Label ), DIOVAN (80 Mg, D, Oral, 40 Mg, D, Oral) (View Diovan Review and Diovan Label ), CELECOXIB (200 Mg, D, Oral) (View Celecoxib Review and Celecoxib Label ). Patient was hospitalized.

6929124-1 | Diabetes Insipidus
Patient was taking Tacrolimus (View Usage). Patient had the following side effects: diabetes insipidus (What is diabetes insipidus?) on Jul 28, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 42 years of age, was diagnosed with renal transplant and. Tacrolimus dosage: .

6929123-X | Diabetes Insipidus
Adverse event was reported on Jul 28, 2010 by a Male patient taking Tacrolimus (View Usage) (Dosage: ) was diagnosed with immunosuppression and. Location: UNITED KINGDOM , 29 years of age, After Tacrolimus was administered, patient had the following side effects: diabetes insipidus (What is diabetes insipidus?).

6929122-8 | Abortion Missed, Blood Pressure Increased, Condition Aggravated, Glucose Urine Present, Lupus Nephritis, Platelet Count Decreased
on Aug 03, 2010 Female patient from JAPAN , 35 years of age, weighting 132.3 lb, was diagnosed with lupus nephritis and was treated with Tacrolimus (View Usage). Patient experienced the following unwanted or unexpected effects: abortion missed, blood pressure increased, condition aggravated, glucose urine present, lupus nephritis, platelet count decreased. Tacrolimus dosage: 2 Mg, Oral; 3 Mg, Oral. During the same period patient was treated with PREDNISOLONE TAB (20 Mg, Qod, Oral; 30 Mg, Oral; 25 Mg, Oral; 20 Mg, Oral) (View Prednisolone Tab Review and Prednisolone Tab Label ). Patient was hospitalized.

6928155-5 | Bacterial Infection, Cerebral Haemorrhage, Chronic Allograft Nephropathy, Nephropathy Toxic, Off Label Use, Platelet Count Decreased, Secondary Amyloidosis, Transplant Failure
on Jul 28, 2010 Female patient from SPAIN , 38 years of age, was diagnosed with pyoderma gangrenosum, renal transplant and was treated with Tacrolimus (View Usage). Patient had the following side effects: bacterial infection (What is bacterial infection?), cerebral haemorrhage, chronic allograft nephropathy, nephropathy toxic, off label use, platelet count decreased, secondary amyloidosis, transplant failure. Tacrolimus dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6926273-9 | Alanine Aminotransferase Increased
Patient was taking Tacrolimus (View Usage). After Tacrolimus was administered, patient had the following side effects: alanine aminotransferase increased on Aug 16, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 150.4 lb, was diagnosed with liver transplant (What is liver transplant?) and. Tacrolimus dosage: Tacrolimus 1mg 5 Caps Bid Po.

6925908-4 | Renal Artery Stenosis, Renal Impairment
Adverse event was reported on Jul 30, 2010 by a Male patient taking Tacrolimus (View Usage) (Dosage: 1.5 Mg/day, Oral) was diagnosed with renal transplant, hypertension and. Location: SPAIN , 46 years of age, weighting 155.2 lb, Patient experienced the following unwanted or unexpected effects: renal artery stenosis, renal impairment. During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ). Patient was hospitalized.

6925351-8 | Glaucoma
on Aug 02, 2010 Male patient from SPAIN , weighting 207.2 lb, was diagnosed with liver transplant (What is liver transplant?) and was treated with Tacrolimus (View Usage). Patient had the following side effects: glaucoma (What is glaucoma?). Tacrolimus dosage: 6 Mg, D, Oral. Patient was hospitalized.

6925344-0 | Lymphadenopathy, Mononucleosis Syndrome
on Aug 03, 2010 Female patient from POLAND , child 8 years of age, was diagnosed with dermatitis infected and was treated with Tacrolimus (View Usage). After Tacrolimus was administered, patient had the following side effects: lymphadenopathy, mononucleosis syndrome. Tacrolimus dosage: 0.1%, D.

6919633-3 | Diabetes Insipidus, Urine Osmolarity Decreased
Patient was taking Tacrolimus (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes insipidus (What is diabetes insipidus?), urine osmolarity decreased on Jul 28, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 41 years of age, . Tacrolimus dosage: .

6919579-0 | Chorioretinopathy, Renal Disorder
Adverse event was reported on Jul 29, 2010 by a Female patient taking Tacrolimus (View Usage) (Dosage: 1 Mg, /d, Oral; 2 Mg, /d, Oral; 1 Mg, /d, Oral) was diagnosed with lupus nephritis and. Location: JAPAN , 58 years of age, weighting 98.77 lb, Patient had the following side effects: chorioretinopathy, renal disorder. During the same period patient was treated with PREDNISOLONE (See Image) (View Prednisolone Review and Prednisolone Label ).

6916809-6 | Lymphadenopathy, Mononucleosis Syndrome
on Jul 26, 2010 Female patient from POLAND , child 8 years of age, was diagnosed with dermatitis atopic and was treated with Tacrolimus (View Usage). After Tacrolimus was administered, patient had the following side effects: lymphadenopathy, mononucleosis syndrome. Tacrolimus dosage: . Patient was hospitalized.

6916495-5 | Allergy Test, Eosinophil Cationic Protein Increased, Granulocyte Count Increased
on Jul 22, 2010 Male patient from GERMANY , child 4 years of age, weighting 33.73 lb, was diagnosed with dermatitis atopic and was treated with Tacrolimus (View Usage). Patient experienced the following unwanted or unexpected effects: allergy test, eosinophil cationic protein increased, granulocyte count increased. Tacrolimus dosage: D, Topical. Patient was hospitalized.

6915524-2 | Osteonecrosis
Patient was taking Tacrolimus (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?) on Jul 26, 2010 from JAPAN Additional patient health information: Female patient , 15 years of age, weighting 139.3 lb, was diagnosed with lupus nephritis and. Tacrolimus dosage: 1.5 Mg/d, Oral; 3 Mg, Oral. During the same period patient was treated with PREDNISOLONE (40 Mg, Oral; 36 Mg, Oral; 12 Mg, Oral; 11 Mg, Oral; 10 Mg, Oral; 9 Mg, Oral) (View Prednisolone Review and Prednisolone Label ), METHYLPREDNISOLONE (See Image) (View Methylprednisolone Review and Methylprednisolone Label ).